Syndax Pharmaceuticals SNDX Return on invested capital

Return on invested capital at other companies

BiogenBIIB

4.6%-3.5pp

IncyteINCY

62.6%+24.7pp

SELLAS Life Sciences Group, Inc.SLS

-4,437.7%—

Kura OncologyKURA

-149.3%-301pp

AbbVieABBV

17.1%—

ArriVent BioPharma, Inc.AVBP

-75.6%-28.0pp

FAQ

What is Syndax Pharmaceuticals's return on invested capital?

Syndax Pharmaceuticals (SNDX) reported return on invested capital of -67.9% in Q1 2026.

How has Syndax Pharmaceuticals's return on invested capital changed year-over-year?

Syndax Pharmaceuticals's return on invested capital increased by 23.4% year-over-year, from -88.6% to -67.9%.

What is the long-term trend for Syndax Pharmaceuticals's return on invested capital?

Over 5 years (2020 to 2025), Syndax Pharmaceuticals's return on invested capital has grown at a -12.6% compound annual growth rate (CAGR), from -98.3% to -50.3%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.